Repotrectinib is a medicine that focuses on treating ROS1-positive non-small cell lung cancer and cancer with NTRK-fusion. The medicine is made to slow down the work of several enzymes linked to these cancers. You can get repotrectinib in 40 mg capsules.
For the first two weeks, you take 160 mg once a day, then you switch to 160 mg taken twice a day after that. Your repotrectinib comes in bottles with 60 caps in them. It works by going after and holding back the TRK, ROS1, and ALK kinases.
These are the key players that make tumors grow in ROS1-positive lung cancer and NTRK-fusion cancers.
